Literature DB >> 9188612

Effects of nucleotide changes on the ability of hepatitis delta virus to transcribe, process, and accumulate unit-length, circular RNA.

T T Wu1, H J Netter, D W Lazinski, J M Taylor.   

Abstract

The circular RNA genome of hepatitis delta virus (HDV) can fold into an unbranched rodlike structure. We mutagenized the two ends of this structure and assayed the effects on the ability of the genomes to replicate and accumulate processed RNA transcripts in transfected cells. The top end, defined as that nearest to the 5' end of the putative mRNA for delta antigen, was much more sensitive than the other end, defined as the bottom. Most of the 22 mutants made at the bottom were able to accumulate RNA as well as the wild type. For deletions extending as close as 2 nucleotides (nt) from the predicted domains needed for the two ribozymes, the accumulation levels dropped to <0.1%. In one mutant, 13 nt of HDV was replaced with 57 nt of non-HDV sequences, and accumulation was at 20% of the wild-type level, consistent with the potential of HDV to act as a vector. However, after replacement with a second sequence, accumulation dropped to 1%. For most of the 14 mutants made at the top of the rod, we observed dramatic inhibitory effects. For example, after removal of 3 bp from the stem adjacent to the terminal loop, accumulation dropped to <0.06% of the wild-type genome level. The top region that we considered was adjacent to both the 5' end of the putative mRNA and the domain that has been proposed to contain a promoter for RNA-directed RNA synthesis. The RNA accumulation abilities of certain mutants were tested under additional different experimental conditions. It was found that after longer times, some mutants began to catch up with the wild type. Also, it was found that certain top mutants gave much greater levels of accumulation when transfected into cells containing the small delta antigen. One interpretation of these data is that certain features at the top of the rod are needed for the accumulation of essential delta antigen mRNA species.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9188612      PMCID: PMC191780          DOI: 10.1128/JVI.71.7.5408-5414.1997

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Identification and characterization of a hepatitis delta virus RNA transcriptional promoter.

Authors:  M R Beard; T B MacNaughton; E J Gowans
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

2.  A novel form of hepatitis delta antigen.

Authors:  V V Bichko; Y E Khudyakov; J M Taylor
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

3.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

4.  Redistribution of the delta antigens in cells replicating the genome of hepatitis delta virus.

Authors:  V V Bichko; J M Taylor
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 5.  The molecular biology of hepatitis delta virus.

Authors:  M M Lai
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

Review 6.  Pathogenesis associated with replication of hepatitis delta virus.

Authors:  V Bichko; H J Netter; T T Wu; J Taylor
Journal:  Infect Agents Dis       Date:  1994 Apr-Jun

7.  SV40-transformed simian cells support the replication of early SV40 mutants.

Authors:  Y Gluzman
Journal:  Cell       Date:  1981-01       Impact factor: 41.582

8.  A pseudoknot ribozyme structure is active in vivo and required for hepatitis delta virus RNA replication.

Authors:  K S Jeng; A Daniel; M M Lai
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.

Authors:  H Nakabayashi; K Taketa; K Miyano; T Yamane; J Sato
Journal:  Cancer Res       Date:  1982-09       Impact factor: 12.701

10.  Nucleotide sequence stability of the genome of hepatitis delta virus.

Authors:  H J Netter; T T Wu; M Bockol; A Cywinski; W S Ryu; B C Tennant; J M Taylor
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

View more
  22 in total

1.  Characterization of the 5' ends for polyadenylated RNAs synthesized during the replication of hepatitis delta virus.

Authors:  S Gudima; K Dingle; T T Wu; G Moraleda; J Taylor
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Interactions between hepatitis delta virus proteins.

Authors:  G Moraleda; K Dingle; P Biswas; J Chang; H Zuccola; J Hogle; J Taylor
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  Specific HDV RNA-templated transcription by pol II in vitro.

Authors:  J Filipovska; M M Konarska
Journal:  RNA       Date:  2000-01       Impact factor: 4.942

4.  Increased RNA editing and inhibition of hepatitis delta virus replication by high-level expression of ADAR1 and ADAR2.

Authors:  Geetha C Jayan; John L Casey
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Alternative processing of hepatitis delta virus antigenomic RNA transcripts.

Authors:  Xingcao Nie; Jinhong Chang; John M Taylor
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 6.  Hepatitis delta virus: A fascinating and neglected pathogen.

Authors:  Celso Cunha; João Paulo Tavanez; Severin Gudima
Journal:  World J Virol       Date:  2015-11-12

7.  Evolution of hepatitis delta virus RNA genome following long-term replication in cell culture.

Authors:  Jinhong Chang; Severin O Gudima; John M Taylor
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

8.  Parameters of human hepatitis delta virus genome replication: the quantity, quality, and intracellular distribution of viral proteins and RNA.

Authors:  Severin Gudima; Jinhong Chang; Gloria Moraleda; Anna Azvolinsky; John Taylor
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

9.  Replication of the human hepatitis delta virus genome Is initiated in mouse hepatocytes following intravenous injection of naked DNA or RNA sequences.

Authors:  J Chang; L J Sigal; A Lerro; J Taylor
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

10.  Transcription of hepatitis delta antigen mRNA continues throughout hepatitis delta virus (HDV) replication: a new model of HDV RNA transcription and replication.

Authors:  L E Modahl; M M Lai
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.